Domov › Crohnova choroba › Texas › Tyler
Klinické štúdie Crohnova choroba v meste Tyler, TX
16 štúdií pre Crohnova choroba hľadá účastníkov v zariadeniach v meste Tyler a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Prebieha náborFáza 3
- Tyler Research Institute ( Site 0294), Tyler
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Prebieha náborFáza 3
- Tyler Research Institute ( Site 5001), Tyler
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Prebieha náborFáza 2
- Tyler Research Institute /ID# 265545, Tyler
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Prebieha náborFáza 3
- The University of Texas Health Science Center at Tyler, Tyler
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Prebieha náborFáza 2/3
- Tyler Research Institute, LLC, Tyler
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Prebieha náborFáza 2
- Tyler Research Institute, LLC, Tyler
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Prebieha náborFáza 3
- Tyler Research Institute, Tyler
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Prebieha náborFáza 3
- Tyler Research Institute, LLC-Site Number: 8400095, Tyler
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Prebieha náborFáza 3
- Tyler Research Institute LLC-Site Number: 8400095, Tyler
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Prebieha náborFáza 2
- Tyler Research Institute, LLC, Tyler
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Prebieha náborFáza 4
- Tyler Research Institute, LLC, Tyler
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Prebieha náborFáza 3
- Tyler Research Institute, LLC, Tyler
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Prebieha náborFáza 3
- Tyler Research Institute, LLC, Tyler
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Prebieha náborFáza 2
- Tyler Research Institute, LLC, Tyler
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Prebieha náborFáza 2
- Tyler Research Institute, LLC, Tyler
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Prebieha náborFáza 2
- Mirador Therapeutics Selected Site, Tyler
Štúdie Crohnova choroba v iných mestách
- New York City, NY35 štúdií
- Cleveland, OH19 štúdií
- St. Louis, MO19 štúdií
- Boston, MA19 štúdií
- Miami, FL19 štúdií
- Orlando, FL17 štúdií
- Houston, TX17 štúdií
- Atlanta, GA17 štúdií
- San Diego, CA15 štúdií
- San Antonio, TX15 štúdií
- Los Angeles, CA15 štúdií
- Philadelphia, PA13 štúdií
Iné štúdie v Tyler
- Nemalobunkový karcinóm pľúc20 štúdií
- Ulcerózna kolitída14 štúdií
- Kolorektálny karcinóm8 štúdií
- Srdcové zlyhanie8 štúdií
- Rakovina (všetky typy)7 štúdií
- Rakovina vaječníkov7 štúdií
- Rakovina endometria6 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku6 štúdií
- Rakovina prsníka6 štúdií
- Metastatická rakovina5 štúdií
- Zápalové ochorenie čriev5 štúdií
- Chronická lymfocytová leukémia5 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.